| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | -5.6% |
| R&D Expense | $125.9M | +84.1% |
| SG&A Expense | $41.8M | +1.8% |
| Operating Income | -$157.7M | -59.5% |
| Income Tax | $0 | — |
| Net Income | -$113.6M | -64.7% |
| EPS (Basic) | -$1.83 | -43.0% |
| EPS (Diluted) | -$1.83 | -43.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.3M | -87.8% |
| Short-term Investments | $914.2M | +53.8% |
| Current Assets | $975.9M | -5.6% |
| Total Assets | $1.00B | -5.6% |
| Current Liabilities | $25.0M | +43.2% |
| Total Liabilities | $44.7M | +15.5% |
| Stockholders' Equity | $956.8M | -6.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.2M | -87.7% |
| Capital Expenditures | $1.0M | +190.5% |
| Investing Cash Flow | -$301.0M | -16.6% |
| Financing Cash Flow | $4.9M | -99.3% |
| Free Cash Flow | -$83.3M | -88.5% |